NEWARK, Calif. (AP) _ Protagonist Therapeutics Inc. (PTGX) on Monday reported a loss of $36.9 million in its fourth quarter.On a per-share basis, the Newark, California-based company said it had a loss of 77 cents.The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 79 cents per share.The biopharmaceutical company posted revenue of $8.6 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $7.4 million.For the year, the company reported a loss of $125.6 million, or $2.71 per share. Revenue was reported as $27.4 million._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTGX at https://www.zacks.com/ap/PTGX